PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets

Equine Pharmaceuticals

Product Description

PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets are indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona in horses. Safe, easy and effective, PROTAZIL starts working fast against disease where time matters.

Product NamePkg SizeGTIN#/UPC#UIN#
PROTAZIL®2.4lb PailNo PK GTIN052850

Images

PROTAZIL® (4/pack)

Important Safety Information

PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets: PROTAZIL® is contraindicated in horses with known hypersensitivity to diclazuril. Safe use in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated. The safety of PROTAZIL® with concomitant therapies in horses has not been evaluated. For use in horses only. Do not use in horses intended for human consumption. For complete safety information please read label.